Berberine Extraction Plant
Alkaloid Extraction Plants

Berberine Extraction Plant

Berberine Extraction Plant

Berberine Extraction Plant

Mechotech designs and manufactures industrial berberine extraction and purification plants for the production of berberine chloride and berberine sulphate (C₂₀H₁₇NO₄·salt) at 95–98% purity from Berberis vulgaris (barberry), Berberis aristata (Indian barberry / tree turmeric / daru haridra), and Coptis chinensis (goldthread). Berberine is a quaternary isoquinoline alkaloid with a broad spectrum of pharmacological activities including antimicrobial, antidiabetic, antidiarrheal, and cardioprotective actions, driving strong global demand from pharmaceutical and nutraceutical manufacturers. Mechotech's plants are available in capacities from 100 kg to 3,000 kg root/bark per batch.

Berberine (C₂₀H₁₇NO₄) is a quaternary ammonium compound and does not require basification for precipitation; instead, berberine salts crystallise selectively from acidic or neutral solution, making its isolation chemistry distinct from other alkaloids. Mechotech's berberine extraction process uses hot ethanol extraction of the plant matrix, followed by acidification to selectively precipitate berberine as its sulphate or chloride salt, with recrystallisation to achieve 95–98% purity. All plants include explosion-proof electrical installations, closed-loop ethanol recovery (>95%), and full batch documentation for pharmaceutical API compliance under WHO-GMP, Indian Schedule M, and USFDA inspection readiness.

Manufacturing Process

1

Plant Material Preparation

Berberis aristata root bark, stem bark, or roots are dried to below 12% moisture and coarsely ground to 0.5–2 mm particle size. Incoming material is tested for berberine content by HPLC (B. aristata root typically contains 2–4% berberine; B. vulgaris bark 0.5–2%; Coptis chinensis rhizome 5–8%). Batch size is adjusted to target a consistent berberine input. The bright yellow colour of the raw material (from berberine and related protoberberine alkaloids) is a visual quality indicator.

2

Hot Ethanol Extraction

Ground plant material is extracted with 60–70% aqueous ethanol at 60–70°C for 3–4 hours under agitation in a jacketed SS 316L extraction vessel. The aqueous ethanol efficiently extracts berberine and co-alkaloids (berberastine, palmatine, jatrorrhizine). Two to three sequential extraction stages are employed with fresh solvent each time to maximise berberine recovery. The combined ethanolic extracts are filtered through a pressure leaf filter and cartridge polishing filters to remove marc and particulates.

3

Concentration & Acid Precipitation

Filtered ethanol extract is concentrated by vacuum evaporation at 50–55°C to remove ethanol (recovered for reuse). The aqueous concentrate is acidified with dilute hydrochloric acid (pH 2–4) or dilute sulphuric acid to convert berberine to its hydrochloride or sulphate salt respectively. At this pH, berberine salt is highly soluble, so the solution is further concentrated and cooled to 5–10°C to initiate salt crystallisation. Berberine sulphate has lower aqueous solubility than the chloride and precipitates more readily.

4

Solvent Extraction / Selective Crystallisation

Crude berberine precipitate collected by centrifugation is redissolved in hot 60% ethanol and treated with activated carbon (1–2% w/v) at 60°C for 30 minutes to remove coloured co-alkaloids and phenolic impurities. After hot filtration, the clarified amber-yellow solution is cooled slowly to 10°C with controlled agitation. Berberine salt crystallises as orange-yellow needles or prisms. The crystals are centrifuged, washed with cold 40% ethanol, and collected.

5

Recrystallisation for High Purity

For pharmaceutical-grade (95–98%) berberine, the collected crystals are recrystallised once or twice from dilute ethanol-water mixtures (50–60% v/v) with activated carbon treatment. Each recrystallisation removes co-alkaloids — particularly palmatine (which has similar solubility) and berberastine — improving berberine assay. Water content is critical: too dilute a solvent gives low recovery; too concentrated gives impure product. HPLC in-process testing guides the recrystallisation endpoint.

6

Drying & QC Testing

Purified berberine chloride or sulphate crystals are dried in a vacuum tray dryer at 50–60°C to moisture below 2% (berberine salts are hygroscopic and require careful drying and packaging). Finished product is tested by HPLC for berberine assay (target 95–98%), related alkaloid impurities (palmatine, jatrorrhizine below specified limits), residual solvents by headspace GC, heavy metals by ICP-MS, and microbial quality. Product is filled into sealed HDPE drums with desiccant under nitrogen headspace.

Applications

  • Pharmaceutical manufacturing — berberine HCl used in antidiarrheal formulations (oral tablets) at 100–400 mg dose, approved for use in India, China, and many European markets
  • Antidiabetic nutraceuticals — berberine's AMPK-activating, glucose-lowering mechanism (comparable to metformin in clinical trials) drives use in blood sugar management supplements at 500–1500 mg per day
  • Antimicrobial and gut health applications — berberine used in formulations targeting gut dysbiosis, H. pylori infection, SIBO, and antibiotic-resistant diarrhoea
  • Cardiovascular health nutraceuticals — berberine's LDL-lowering, triglyceride-reducing, and anti-arrhythmic properties used in cholesterol management supplements
  • Ayurvedic and traditional medicine — Berberis aristata (daru haridra) is a classical Ayurvedic herb; standardised berberine extract used in GMP herbal proprietary medicines
  • Cosmetics and personal care — berberine's antibacterial and anti-inflammatory properties investigated for acne treatment topical formulations
  • Veterinary medicine — berberine used in animal health products for treatment of diarrhoea and gastrointestinal infections in poultry and livestock

Key Features

  • Selective Salt Crystallisation Process

    Mechotech's berberine extraction leverages the differential solubility of berberine sulphate and chloride versus co-alkaloids (palmatine, jatrorrhizine) to achieve high-purity berberine in fewer recrystallisation steps than generic solvent extraction. The acidification-selective crystallisation design consistently delivers 95–98% berberine assay from the first recrystallisation.

  • Activated Carbon Decolourisation System

    Berberine-bearing plant extracts contain intensely coloured co-alkaloids and tannins. Mechotech's plants include dedicated activated carbon treatment vessels with hot filtration systems to remove coloured impurities before crystallisation, ensuring the finished berberine product meets the yellow to orange-yellow colour specifications of pharmacopoeial monographs rather than the dark brown colour of crude extract.

  • GMP SS 316L Construction with Schedule M Compliance

    All product-contact equipment is fabricated in SS 316L with electro-polished surfaces, equipped with validated CIP cleaning systems, and designed to Indian Schedule M / WHO-GMP standards for bulk pharmaceutical ingredient manufacture, supporting the plant's use in producing berberine for regulated pharmaceutical product formulations.

  • Closed-Loop Ethanol Recovery (>95%)

    Ethanol from extraction, concentration, and recrystallisation steps is recovered in a dedicated distillation column, achieving greater than 95% ethanol recycling. Recovered ethanol is tested for strength and purity before re-use. This dramatically reduces operating cost (ethanol is the largest variable cost in berberine production) and complies with CPCB norms for solvent discharge.

  • In-Process HPLC Testing Capability

    Mechotech's plant package includes sampling ports at each key processing stage — extraction, concentration, crystallisation, and recrystallisation — with documentation for in-process HPLC testing. This allows real-time purity monitoring and end-point determination for each batch, reducing the risk of out-of-specification product and supporting pharmaceutical-grade batch release documentation.

Frequently Asked Questions

What is the berberine content of different source plants and which gives the best extraction economics?
Berberine content varies widely by species and plant part: Coptis chinensis rhizome (8–10% berberine) is the richest source but is expensive and primarily sourced from China. Berberis aristata root bark (2–4%) is the most widely used and most economical source in India, with abundant cultivation in Himachal Pradesh and Uttarakhand. Berberis vulgaris (barberry) bark and root (0.5–2%) is lower-yielding and less economic for dedicated extraction. For Indian manufacturers, B. aristata root bark provides the best combination of availability, berberine concentration, and extraction economics. Mechotech designs extraction parameters specifically for each source material.
What is the difference between berberine chloride and berberine sulphate, and which is more commonly specified?
Berberine HCl (berberine chloride) and berberine sulphate are the two primary pharmaceutical salt forms. Berberine HCl has higher water solubility, better bioavailability in capsule formulations, and is the form specified in the Indian Pharmacopoeia (IP), USP, and Chinese Pharmacopoeia for oral antidiarrheal tablets. Berberine sulphate has lower water solubility, is easier to crystallise to high purity in the extraction process, and is sometimes specified in older formulations. Most nutraceutical and pharmaceutical buyers today specify berberine HCl. Mechotech's plants can produce either salt form with an adjustment in the acidification step.
How does Mechotech's berberine plant address the challenge of separating berberine from closely related co-alkaloids like palmatine?
Palmatine (a co-alkaloid in Berberis species, with very similar structure and chromatographic behaviour to berberine) is the principal purity challenge in berberine manufacture. Mechotech's process addresses this through: (1) selective crystallisation conditions — berberine sulphate has slightly lower solubility than palmatine sulphate, allowing enrichment; (2) activated carbon treatment that preferentially removes more polar co-alkaloids; and (3) double recrystallisation for pharmaceutical-grade product. In-process HPLC testing at each crystallisation stage enables batch-specific adjustment of recrystallisation cycles to meet the pharmacopoeial limit for related alkaloids (typically palmatine below 2% by HPLC).
What capacity range does Mechotech offer for berberine extraction plants and what is the typical production rate?
Mechotech's berberine extraction plants are offered in batch sizes of 100 kg to 3,000 kg plant material per extraction cycle. For B. aristata root bark at 3% berberine content with 75% extraction efficiency and 85% crystallisation yield: a 1,000 kg batch yields approximately 19 kg of purified berberine salt per cycle. For a plant running two cycles per day, 300 operational days per year, this represents approximately 11,400 kg (11.4 MT) of berberine per year from a 1,000 kg plant — sufficient for a mid-scale pharmaceutical ingredient supplier. Mechotech designs multi-vessel extraction trains for larger throughputs.

Ready to discuss your project?

Get a free quote and technical consultation from our engineering team.

Get A Free Quote
Review Us